Company Filing History:
2 out of 2,079 
2 out of 363 
1 out of 1,458 
Years Active: 2009-2022
Title: Edward John Yurkow: Innovator in Toxicology Mitigation
Introduction
Edward John Yurkow is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of toxicology, particularly in developing methods to mitigate the effects of harmful substances. With a total of 4 patents to his name, Yurkow's work has the potential to impact public health and safety.
Latest Patents
Yurkow's latest patents include innovative methods for mitigating the toxic effects of vesicants and caustic gases. One of his notable inventions describes methods and kits that utilize an effective amount of a thrombopoietin (TPO) mimetic, such as RWJ-800088 or romiplostim, to alleviate the toxic effects of these harmful agents. Additionally, he has developed peptide compounds that bind to and activate the thrombopoietin receptor (c-mpl or TPO-R), acting as TPO agonists to further enhance the mitigation of toxic effects.
Career Highlights
Throughout his career, Yurkow has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His experience in these organizations has allowed him to refine his expertise in toxicology and drug development.
Collaborations
Yurkow has collaborated with several professionals in his field, including Brian R. MacDonald and Jeffery Kenneth Weis. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Edward John Yurkow is a distinguished inventor whose work in toxicology mitigation has the potential to save lives and improve health outcomes. His innovative patents and collaborations reflect his commitment to advancing science and technology in this critical area.